DURECT Corp (NASDAQ:DRRX)
CAPS Rating:
The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.
RSS Headlines
Fool UK
Recs
have a nice mature pipeline and cheap right now
loaded up on this one lately. Looking for some big news coming soon. ;)